Scottish HTA Nod For Keytruda In Endometrial Carcinoma Marks UK First
Executive Summary
Scotland has approved reimbursement for MSD’s Keytruda in combination with Eisai’s Lenvima for endometrial carcinoma. Meanwhile, a recommendation in England has been delayed.